Niet voor menselijk gebruik of diagnostische/therapeutische toepassingen
Overall, these findings reveal that tirzepatide can reduce diabetes-related cardiac damage, implying therapeutic potential for heart failure therapy
Patients on tirzepatide were twice as likely to lose at least 25% of their body weight, and nearly one in five (19.7%) lost 30% or more, compared to fewer than one in fourteen (6.9%) on semaglutide.[1] Both medications also improved blood pressure, blood sugar, and cholesterol levels, with greater improvements seen in the tirzepatide group, which tracked with the larger weight reduction.[1] The safety profiles were similar
1,990.00 Rs
AOD-9604, a fragment of human growth hormone, stimulates lipolysis while simultaneously inhibiting lipogenesis
Not Sure How Your Metabolism Is Working